New Hope in Fighting Breast Cancer: Understanding the Targeted Drug Verzenio (Abemaciclib)

Verzenio has opened a new window of hope for many patients with HR-positive, HER2-negative breast cancer. The Challenge of Breast Cancer HR-positive, HER2-negative breast cancer, as the most common subtype, has long relied primarily on…











